Celltrion
068270.KS
99,83 €
Share price
-1.89%
Change (1 day)
-20.02%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Earnings for Celltrion (068270.KS)
Earnings in 2024 (TTM): €0.43 Billion
According to Celltrion 's latest financial reports the company's current earnings are €2.58 Billion. a decrease over its 2023 earnings that were of €0.45 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Celltrion from 2008 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | €0.41 B | -8.8% |
| 2023 | €0.45 B | 6.8% |
| 2022 | €0.42 B | -21.85% |
| 2021 | €0.54 B | 10.25% |
| 2020 | €0.49 B | 65.16% |
| 2019 | €0.29 B | 16.64% |
| 2018 | €0.25 B | -33.89% |
| 2017 | €0.38 B | 106.53% |
| 2016 | €0.18 B | 25.57% |
| 2015 | €0.14 B | -6.54% |
| 2014 | €0.15 B | 47.36% |
| 2013 | €0.10 B | -33.63% |
| 2012 | €0.16 B | |
| 2010 | €84.33 M | 72.84% |
| 2009 | €48.79 M | 260.54% |
| 2008 | €13.53 M |